129 related articles for article (PubMed ID: 9928763)
1. Immunohistochemical study on phenotypical changes of hepatocytes in liver disease with reference to extracellular matrix composition.
Matsumoto S; Yamamoto K; Nagano T; Okamoto R; Ibuki N; Tagashira M; Tsuji T
Liver; 1999 Feb; 19(1):32-8. PubMed ID: 9928763
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6.
Crosby HA; Hubscher S; Fabris L; Joplin R; Sell S; Kelly D; Strain AJ
Am J Pathol; 1998 Mar; 152(3):771-9. PubMed ID: 9502419
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of cell-matrix adhesion molecules and their ligands in the portal tracts of primary biliary cirrhosis.
Yasoshima M; Tsuneyama K; Harada K; Sasaki M; Gershwin ME; Nakanuma Y
J Pathol; 2000 Jan; 190(1):93-9. PubMed ID: 10640998
[TBL] [Abstract][Full Text] [Related]
4. Site-characteristic expression and induction of trefoil factor family 1, 2 and 3 and malignant brain tumor-1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology.
Sasaki M; Tsuneyama K; Saito T; Kataoka H; Mollenhauer J; Poustka A; Nakanuma Y
Liver Int; 2004 Feb; 24(1):29-37. PubMed ID: 15101998
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis.
Hashimoto E; Lindor KD; Homburger HA; Dickson ER; Czaja AJ; Wiesner RH; Ludwig J
Mayo Clin Proc; 1993 Nov; 68(11):1049-55. PubMed ID: 8231268
[TBL] [Abstract][Full Text] [Related]
6. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural localization of the major components of the extracellular matrix in normal mouse liver.
Baranov V; Rescan PY; Rissel M; Grimaud JA; Guillouzo A
J Submicrosc Cytol Pathol; 1990 Oct; 22(4):497-506. PubMed ID: 2282637
[TBL] [Abstract][Full Text] [Related]
8. The hepatic extracellular matrix. I. Electron immunohistochemical studies in normal rat liver.
Martinez-Hernandez A
Lab Invest; 1984 Jul; 51(1):57-74. PubMed ID: 6376944
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of laminin, nidogen, and type IV collagen during the early development of human liver.
Quondamatteo F; Scherf C; Miosge N; Herken R
Histochem Cell Biol; 1999 Jan; 111(1):39-47. PubMed ID: 9930882
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of cytokeratin 7 as a histological marker of progression in primary biliary cirrhosis.
Yabushita K; Yamamoto K; Ibuki N; Okano N; Matsumura S; Okamoto R; Shimada N; Tsuji T
Liver; 2001 Feb; 21(1):50-5. PubMed ID: 11169073
[TBL] [Abstract][Full Text] [Related]
11. Ontogenesis of the murine hepatic extracellular matrix: an immunohistochemical study.
Baloch Z; Klapper J; Buchanan L; Schwartz M; Amenta PS
Differentiation; 1992 Nov; 51(3):209-18. PubMed ID: 1459362
[TBL] [Abstract][Full Text] [Related]
12. A cytokeratin immunohistochemical study of cholestatic liver disease: evidence that hepatocytes can express 'bile duct-type' cytokeratins.
Van Eyken P; Sciot R; Desmet VJ
Histopathology; 1989 Aug; 15(2):125-35. PubMed ID: 2476370
[TBL] [Abstract][Full Text] [Related]
13. Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: an immunohistochemical study.
Tsuneyama K; Harada K; Yasoshima M; Kaji K; Gershwin ME; Nakanuma Y
J Pathol; 1998 Oct; 186(2):126-30. PubMed ID: 9924426
[TBL] [Abstract][Full Text] [Related]
14. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohistochemical study.
Sasaki M; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1313-7. PubMed ID: 8675144
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix alteration in chronic hepatitis.
Hsing CH; Leu FJ; Tsao TY; Wang J; Tang HS
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Oct; 48(4):259-66. PubMed ID: 1659920
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of collagen type III and IV in relation with transformation of Ito cells in liver sinusoids of patients with reactive biliary hepatitis.
Gulubova MV; Stoyanov HD; Julianov AE; Vasilev IV; Stoyanova II; Hadjipetkov PB
Acta Histochem; 1999 Apr; 101(2):213-28. PubMed ID: 10335364
[TBL] [Abstract][Full Text] [Related]
17. Biliary expression of heat shock protein: a non-specific feature of chronic cholestatic liver diseases.
Martins EB; Chapman RW; Marron K; Fleming KA
J Clin Pathol; 1996 Jan; 49(1):53-6. PubMed ID: 8666687
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of alpha interferon in liver disease.
Sutherland CG; al-Badri AM; Howatson AG; Farquharson MA; Foulis AK
J Clin Pathol; 1989 Oct; 42(10):1065-9. PubMed ID: 2584407
[TBL] [Abstract][Full Text] [Related]
19. Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. An immunohistochemical study.
Van Eyken P; Sciot R; Desmet VJ
J Hepatol; 1990 Jul; 11(1):43-52. PubMed ID: 1697872
[TBL] [Abstract][Full Text] [Related]
20. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis.
Sasatomi K; Noguchi K; Sakisaka S; Sata M; Tanikawa K
J Hepatol; 1998 Sep; 29(3):409-16. PubMed ID: 9764987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
